Belenguer-Muncharaz A, Albert-Rodrigo L, Ferrandiz-Sellés A, Cebrián-Graullera G
Servicio de Medicina Intensiva, Hospital General de Castellón, Castellón de la Plana, España.
Med Intensiva. 2013 Oct;37(7):452-60. doi: 10.1016/j.medin.2012.12.011. Epub 2013 Jul 25.
A comparison was made between invasive mechanical ventilation (IMV) and noninvasive positive pressure ventilation (NPPV) in haematological patients with acute respiratory failure.
A retrospective observational study was made from 2001 to December 2011.
A clinical-surgical intensive care unit (ICU) in a tertiary hospital.
Patients with hematological malignancies suffering acute respiratory failure (ARF) and requiring mechanical ventilation in the form of either IMV or NPPV.
Analysis of infection and organ failure rates, duration of mechanical ventilation and ICU and hospital stays, as well as ICU, hospital and mortality after 90 days. The same variables were analyzed in the comparison between NPPV success and failure.
Forty-one patients were included, of which 35 required IMV and 6 NPPV. ICU mortality was higher in the IMV group (100% vs 37% in NPPV, P=.006). The intubation rate in NPPV was 40%. Compared with successful NPPV, failure in the NPPV group involved more complications, a longer duration of mechanical ventilation and ICU stay, and greater ICU and hospital mortality. Multivariate analysis of mortality in the NPPV group identified NPPV failure (OR 13 [95%CI 1.33-77.96], P=.008) and progression to acute respiratory distress syndrome (OR 10 [95%CI 1.95-89.22], P=.03) as prognostic factors.
The use of NPPV reduced mortality compared with IMV. NPPV failure was associated with more complications.
对血液系统急性呼吸衰竭患者采用有创机械通气(IMV)和无创正压通气(NPPV)进行比较。
对2001年至2011年12月进行回顾性观察研究。
一家三级医院的临床外科重症监护病房(ICU)。
患有血液系统恶性肿瘤且发生急性呼吸衰竭(ARF)并需要IMV或NPPV形式机械通气的患者。
分析感染和器官衰竭发生率、机械通气持续时间以及ICU和住院时间,以及90天后的ICU、医院死亡率。在NPPV成功与失败的比较中分析相同变量。
纳入41例患者,其中35例需要IMV,6例需要NPPV。IMV组的ICU死亡率更高(100%对NPPV组的37%,P = 0.006)。NPPV组的插管率为40%。与成功的NPPV相比,NPPV组失败涉及更多并发症、机械通气和ICU停留时间更长以及更高的ICU和医院死亡率。NPPV组死亡率的多因素分析确定NPPV失败(比值比13 [95%可信区间1.33 - 77.96],P = 0.008)和进展为急性呼吸窘迫综合征(比值比10 [95%可信区间1.95 - 89.22],P = 0.03)为预后因素。
与IMV相比,使用NPPV可降低死亡率。NPPV失败与更多并发症相关。